Torii Pharmaceutical Co., Ltd.
TRXPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $209,135,062 | $187,345,612 | $174,208,804 | $158,687,955 |
| - Cash | $3 | $5 | $20 | $27 |
| + Debt | $0 | $0 | $1 | $0 |
| Enterprise Value | $209,135,059 | $187,345,608 | $174,208,784 | $158,687,928 |
| Revenue | $60 | $55 | $49 | $47 |
| % Growth | 10.6% | 11.7% | 4.1% | – |
| Gross Profit | $27 | $23 | $23 | $24 |
| % Margin | 44.2% | 41.7% | 47.8% | 51.8% |
| EBITDA | $7 | $6 | $6 | $5 |
| % Margin | 11.8% | 11.1% | 12.2% | 10.7% |
| Net Income | $5 | $4 | $4 | $3 |
| % Margin | 8.3% | 7.5% | 8.1% | 7.2% |
| EPS Diluted | 179.46 | 146.57 | 140.38 | 120.11 |
| % Growth | 22.4% | 4.4% | 16.9% | – |
| Operating Cash Flow | $4 | -$3 | $2 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $3 | -$3 | $2 | -$1 |